APA (7th ed.) Citation

Gandhi, K. A., Joshi, A., Mehta, P., Gurjar, M., Rane, P., Sharma, J., . . . Gota, V. (2022). Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer. Cancer Chemotherapy & Pharmacology, 89(6), 751. https://doi.org/10.1007/s00280-022-04432-4

Chicago Style (17th ed.) Citation

Gandhi, Khushboo A., et al. "Feasibility of Therapeutic Drug Monitoring of Sunitinib and Its Implications on Response and Toxicity in Patients with Metastatic Renal Cell Cancer." Cancer Chemotherapy & Pharmacology 89, no. 6 (2022): 751. https://doi.org/10.1007/s00280-022-04432-4.

MLA (9th ed.) Citation

Gandhi, Khushboo A., et al. "Feasibility of Therapeutic Drug Monitoring of Sunitinib and Its Implications on Response and Toxicity in Patients with Metastatic Renal Cell Cancer." Cancer Chemotherapy & Pharmacology, vol. 89, no. 6, 2022, p. 751, https://doi.org/10.1007/s00280-022-04432-4.